wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34996046-FFFC1141-3249-4DD7-907C-CC8A9D01333E
Q34996046-FFFC1141-3249-4DD7-907C-CC8A9D01333E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34996046-FFFC1141-3249-4DD7-907C-CC8A9D01333E
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study
P2860
Q34996046-FFFC1141-3249-4DD7-907C-CC8A9D01333E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34996046-FFFC1141-3249-4DD7-907C-CC8A9D01333E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d718d0e64e605c12d35ef42f91e3872c141916d9
P2860
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer